Ken Griffin Atri Cure, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,300 shares of ATRC stock, worth $402,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,300
Previous 12,000
2.5%
Holding current value
$402,087
Previous $336,000
11.61%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ATRC
# of Institutions
229Shares Held
47.1MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$152 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$151 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$125 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$95.6 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$82.7 Million0.51% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.52B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...